Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Acurx Pharmaceuticals, Inc. (ACXP) had Return on Equity of -62.99% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.25M |
|
-- |
|
-- |
|
$2.27M |
|
$-2.27M |
|
$0.02M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.27M |
|
$-2.27M |
|
1.19M |
|
1.19M |
|
$-1.89 |
|
$-1.89 |
|
| Balance Sheet Financials | |
$6.16M |
|
-- |
|
-- |
|
$6.16M |
|
$2.59M |
|
-- |
|
-- |
|
$2.59M |
|
$3.57M |
|
$3.57M |
|
$3.57M |
|
1.47M |
|
| Cash Flow Statement Financials | |
$-3.72M |
|
-- |
|
$6.08M |
|
$3.71M |
|
$6.06M |
|
$2.36M |
|
$0.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-62.99% |
-62.99% |
|
-36.48% |
|
-62.99% |
|
$2.43 |
|
$-3.13 |
|
$-3.13 |
|